THE GENE TO ANTIBODY COMPANY
Live / Registered — Registered (as of 02 Jan 2024)
What this means for you
Registered since 02 Jan 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97382404
- Registration number
- 7264779
- Mark type
- Stylized text
- Filed
- 26 Apr 2022
- Registered
- 02 Jan 2024
- Attorney of record
- Thomas Kading
Goods and services
- Class 040 — Treatment of materials: Biomanufacturing for others, namely, manufacturing of antibodies, proteins, and plasmids using biological organisms in the manufacturing process
- Class 042 — Scientific and technological services: Biotechnology research; Development of new technology for others in the field of biotechnology and pharmaceuticals; Laboratory research services relating to pharmaceuticals; Pharmaceutical research and development; Pharmaceutical research services; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research on the subject of pharmaceuticals; Research and development in the pharmaceutical and biotechnology fields; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing information on the subject of scientific research in the field of biochemistry and biotechnology
Owner
- Genovac Antibody Discovery LLC, Fargo, ND, US
- Genovac Antibody Discovery LLC, Fargo, ND, US
Prosecution history
- 02 Jan 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 02 Jan 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 26 Apr 2023 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 26 Apr 2023 — EXAMINER'S AMENDMENT ENTERED
- 26 Apr 2023 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 26 Apr 2023 — EXAMINERS AMENDMENT E-MAILED
- 26 Apr 2023 — EXAMINERS AMENDMENT -WRITTEN
- 15 Mar 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Mar 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Mar 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Feb 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Feb 2023 — NON-FINAL ACTION E-MAILED
- 21 Feb 2023 — NON-FINAL ACTION WRITTEN
- 13 Feb 2023 — ASSIGNED TO EXAMINER
- 02 May 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED